`Wake Up Call: Perkins Coie,
`Expecting 'Transformed'
`Economy, Cuts Pay
`Wire: BLW — 05/14/2020 08:53
`
`A Look At What Some of Big
`Pharma's Top Lawyers Earned in
`2019
`Wire: BLW — 04/01/2020 05:30
`
`Merck, Celgene Drugs Could Be
`Hit By Democratic Pricing Bill
`Wire: BLW — 09/20/2019 07:02
`
`India Infoline: Sun Pharma unit
`raises stake in PJSC Biosintez,
`Russia
`Wire: NS6 — 09/10/2019 23:03
`
`Bombay Stk Exch: Announcement
`under Regulation 30 (LODR)-
`Updates on Acquisition -
`09/09/2019 17:33:04
`Wire: FM6 — 09/09/2019 08:03
`
`MORE
`
`7/9/2020
`
`Bloomberg Law - View Corporate Action
`Prepared for: Shannon Co ey
`
`Acquirer Information
`Sun
`Name:
`Pharmaceutical
`Industries Ltd
`SUNP IN Equity
`Medical-Drugs
`INDIA
`
`Ticker:
`Industry:
`Country:
`
`Target Information
`Ranbaxy
`Name:
`Laboratories Ltd
`RBXY IN Equity
`Medical-Drugs
`INDIA
`
`Ticker:
`Industry:
`Country:
`
`04/06/2014
`09/02/2015
`
`Completed
`Friendly
`0.0%
`100.0%
`
`N/A
`N/A
`Stock
`N/A
`
`INR
`246.7 Bln
`356.2 Bln
`
`50.5 Bln
`
`Important Dates
`
`Announced Date:
`Completion Date:
`
`Details
`
`Status:
`Nature of Bid:
`Percent Owned:
`Percent Sought:
`
`Deal Price:
`Gross Spread:
`Payment Type:
`Cash Terms (per Sh):
`
`Termination Fees
`
`Currency:
`Announced Value:
`Final Value:
`
`Net Debt:
`
`Role
`
`Acquirer Financial Adviser
`
`Acquirer Financial Adviser
`
`Acquirer Financial Adviser
`
`Target Financial Adviser
`
`Target Financial Adviser
`
`Target Financial Adviser
`
`Acquirer Legal Adviser
`
`Acquirer Legal Adviser
`
`Acquirer Legal Adviser
`
`Target Legal Adviser
`
`Target Legal Adviser
`
`Target Legal Adviser
`
`Target Legal Adviser
`
`Target Legal Adviser
`
`Fee
`
`Advisers
`
`Citi
`
`Evercore Partners Inc
`
`Sr Batliboi & Co
`
`GCA Corp
`
`Goldman Sachs
`
`ICICI
`
`Crawford Bayley & Co
`
`SH Bathiya & Co
`
`Shearman & Sterling LLP
`
`Amarchand Mangaldas & Suresh A Shro
`
`Davis Polk & Wardwell
`
`Hogan Lovells US LLP
`
`Luthra & Luthra Law O ces
`
`Morgan Lewis & Bockius LLP
`
`Acquirer Legal to Financial Adviser
`
`Weil Gotshal & Manges LLP
`
`Target Legal to Financial Adviser
`
`Sullivan & Cromwell
`
`Approval By
`
`Target Shareholders
`
`Acquirer Shareholders
`
`Date
`
`Date Type
`
`State
`
`Status
`
`03/24/2015
`
`08/26/2014
`
`E ective
`
`E ective
`
`Approved
`
`Approved
`
`https://www.bloomberglaw.com/company/corp_actions/details/RBXY IN Equity/ACQUISITION/89663096
`
`1/2
`
`Merck Sharp & Dohme Corp. Exhibit 2034
`Teva Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-01045
`
`
`
`7/9/2020
`
`Approval By
`
`High Court
`
`Competition Commission
`
`HSR: Hart-Scott-Rodino
`
`Acquirer Board of Directors
`
`Target Board of Directors
`
`FTC: Federal Trade Commission
`
`Bloomberg Law - View Corporate Action
`
`Date
`
`Date Type
`
`State
`
`Status
`
`03/09/2015
`
`12/08/2014
`
`10/15/2014
`
`04/06/2014
`
`04/06/2014
`
`01/30/2015
`
`E ective
`
`E ective
`
`E ective
`
`E ective
`
`E ective
`
`E ective
`
`Approved
`
`Approved
`
`Early termination
`
`Approved
`
`Approved
`
`Approved
`
`https://www.bloomberglaw.com/company/corp_actions/details/RBXY IN Equity/ACQUISITION/89663096
`
`2/2
`
`Merck Sharp & Dohme Corp. Exhibit 2034
`Teva Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-01045
`
`